Wed, Jul 23, 2014, 9:29 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Galena Biopharma, Inc. Message Board

  • wilvin58 wilvin58 Nov 20, 2013 2:09 PM Flag

    98% Revenue Growth, Could Easily Gain 50%-100%

    Agria (GRO)'s wholly owned China seeds subsidiary grew revenues in fiscal 2013 by 98% to $17 million, yet it's currently being valued at LESS THAN ZERO. If GRO sold their shares of PGG Wrightson (PGW.NZ) at the current New Zealand Exchange market price it would have approximately $174 million in cash and $75 million in debt, for a net cash position of $99 million. With 55.38 million shares outstanding, GRO would have a net cash position of $1.79 per share! GRO is currently trading for only $1.30. Even if GRO's China seeds business is worth only 1X sales or $17 million, GRO deserves to trade for $2.10 per share, up 62% from its current share price. We have already accumulated 550,000 shares of GRO and don't intend to sell until it reaches much higher prices.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
GALE
3.04+0.14(+5.01%)Jul 23 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Gilead Sciences Inc.
NasdaqGSWed, Jul 23, 2014 3:59 PM EDT